Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Anti-plasmodial activity of bradykinin and analogs

Full text
Author(s):
Silva, Adriana F. [1] ; Alves, Falvio L. [2] ; Pedron, Cibele N. [1] ; Torres, Marcelo D. T. [1] ; Silva, Leandro S. [3] ; Pinheiro, Ana A. S. [3] ; Miranda, Antonio [2] ; Oliveira, Jr., Vani X. [1]
Total Authors: 8
Affiliation:
[1] Univ Fed ABC, BR-09210170 Santo Andre - Brazil
[2] Univ Fed Sao Paulo, BR-04044020 Sao Paulo - Brazil
[3] Univ Fed Rio de Janeiro, BR-21941902 Rio De Janeiro - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Bioorganic & Medicinal Chemistry Letters; v. 25, n. 16, p. 3311-3313, AUG 15 2015.
Web of Science Citations: 2
Abstract

To find effective new candidate antimalarial drugs, bradykinin and its analogs were synthesized and tested for effectiveness against Plasmodium gallinaceum sporozoites and Plasmodium falciparum on erythrocytes. Among them, bradykinin and its P-2 analog presented high activity against Plasmodium gallinaceum, but they degrade in plasma. On the other hand, RI-BbKI did not degrade and reached high activity. No analog was active against Plasmodium falciparum. (C) 2015 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 11/15083-3 - Cyclic Antimalariais Derivates of Angiotensin II
Grantee:Marcelo Der Torossian Torres
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 11/10823-9 - Antimalarial compounds derivative from angiotensin II
Grantee:Vani Xavier de Oliveira Junior
Support Opportunities: Regular Research Grants